This article reviews progress made in the creation of a transplantable artificial ovary and discusses future trends for its development.
Browsing: Disease Area > Gynecologic
In 2017, every woman in Australia aged 37 years and younger is already better protected against HPV than ever before – this is a huge milestone and a truly remarkable feat. How was this achieved and what hurdles still exist? Find out in this exclusive opinion piece.
New findings suggest that women who receive human papillomavirus (HPV) testing as well as a Pap smear obtain a faster and more complete diagnosis of cervical disease.
In this editorial from Future Oncology the different types of endometrial cancer are appraised.
In this review article from Future Oncology the authors highlight why we may need to reconsider the grading of cervical intraepithelial neoplasia.
Findings from the largest group of men treated for penile cancer by a single institution have demonstrated the benefits of brachytherapy.
ASCO release guidance for HPV vaccination for cervical cancer prevention adapted for multiple regions of the world with differing socio-economic statuses and structural resource settings.
A new study suggests that the ribosomal protein P-S6S240 could represent a marker of poor prognosis and a therapeutic target in uterine leiomyosarcoma.